, Tracking Stock Market Picks
Enter Symbol:
Autodesk, Inc. (ADSK) [hlAlert]

down 32.27 %

Autodesk, Inc. (ADSK) upgraded to Buy with price target $27 by Needham

Posted on: Tuesday,  Nov 18, 2008  9:25 AM ET by Needham

Needham rated Buy Autodesk, Inc. (NASDAQ: ADSK) on 11/18/2008, when the stock price was $18.96. Since then, Autodesk, Inc.
has lost 32.28% of its value until Needham rated ADSK Hold on 11/21/2008, when the price was $12.84.
If you would have followed this Needham's recommendation on ADSK, you would have lost 32.27% of your investment in 3 days.

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson?s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/24/2010 8:25 AM Buy
28.05 31.00
as of 12/24/2008
1 Week up  6.32 %
1 Month up  32.52 %
3 Months down  -20.88 %
1 YTD up  0.15 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/21/2008 9:25 AM Hold
11/18/2008 9:25 AM Buy
18.96 27.00
8/15/2008 9:25 AM Buy
37.96 45.00
2/27/2008 9:25 AM Hold
8/17/2007 9:25 AM Buy
44.98 55.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy